• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于探讨心脏修复中心律失常发生机制的模型系统。

Model Systems for Addressing Mechanism of Arrhythmogenesis in Cardiac Repair.

作者信息

Zhang Xiao-Dong, Thai Phung N, Lieu Deborah K, Chiamvimonvat Nipavan

机构信息

Division of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Davis, CA, 95616, USA.

Department of Veterans Affairs, Veterans Affairs Northern California Health Care System, Mather, CA, 95655, USA.

出版信息

Curr Cardiol Rep. 2021 May 29;23(6):72. doi: 10.1007/s11886-021-01498-z.

DOI:10.1007/s11886-021-01498-z
PMID:34050853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8164614/
Abstract

PURPOSE OF REVIEW

Cardiac cell-based therapy represents a promising approach for cardiac repair. However, one of the main challenges is cardiac arrhythmias associated with stem cell transplantation. The current review summarizes the recent progress in model systems for addressing mechanisms of arrhythmogenesis in cardiac repair.

RECENT FINDINGS

Animal models have been extensively developed for mechanistic studies of cardiac arrhythmogenesis. Advances in human induced pluripotent stem cells (hiPSCs), patient-specific disease models, tissue engineering, and gene editing have greatly enhanced our ability to probe the mechanistic bases of cardiac arrhythmias. Additionally, recent development in multiscale computational studies and machine learning provides yet another powerful tool to quantitatively decipher the mechanisms of cardiac arrhythmias. Advancing efforts towards the integrations of experimental and computational studies are critical to gain insights into novel mitigation strategies for cardiac arrhythmias in cell-based therapy.

摘要

综述目的

基于心脏细胞的治疗是一种有前景的心脏修复方法。然而,主要挑战之一是与干细胞移植相关的心律失常。本综述总结了用于研究心脏修复中致心律失常机制的模型系统的最新进展。

最新发现

已广泛开发动物模型用于心律失常发生机制的研究。人类诱导多能干细胞(hiPSC)、患者特异性疾病模型、组织工程和基因编辑方面的进展极大地增强了我们探究心律失常机制基础的能力。此外,多尺度计算研究和机器学习的最新发展提供了另一种强大工具,用于定量解读心律失常的机制。推进实验研究与计算研究整合的工作对于深入了解基于细胞治疗中心律失常的新型缓解策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fd/8164614/dec72a62deb0/11886_2021_1498_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fd/8164614/dec72a62deb0/11886_2021_1498_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43fd/8164614/dec72a62deb0/11886_2021_1498_Fig1_HTML.jpg

相似文献

1
Model Systems for Addressing Mechanism of Arrhythmogenesis in Cardiac Repair.用于探讨心脏修复中心律失常发生机制的模型系统。
Curr Cardiol Rep. 2021 May 29;23(6):72. doi: 10.1007/s11886-021-01498-z.
2
Induced pluripotent stem cell-based therapies for inherited arrhythmias: opportunities and challenges involved (Review).基于诱导多能干细胞的遗传性心律失常治疗:相关机遇与挑战(综述)
Mol Med Rep. 2015 Jan;11(1):3-10. doi: 10.3892/mmr.2014.2668. Epub 2014 Oct 16.
3
A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart.一个全面的、多尺度的框架,用于评估心肌梗死后整个心脏中细胞治疗引起的心律失常。
Sci Rep. 2019 Jun 25;9(1):9238. doi: 10.1038/s41598-019-45684-0.
4
Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias.诱导多能干细胞衍生的心肌细胞在遗传性心律失常研究中的应用。
J Clin Invest. 2013 Jan;123(1):84-91. doi: 10.1172/JCI62838. Epub 2013 Jan 2.
5
Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.利用人诱导多能干细胞衍生的心肌细胞片层对短 QT 综合征中的再入现象进行建模。
J Am Coll Cardiol. 2019 May 14;73(18):2310-2324. doi: 10.1016/j.jacc.2019.02.055.
6
Adhesion proteins, stem cells, and arrhythmogenesis.黏附蛋白、干细胞与心律失常的发生机制
Cardiovasc Toxicol. 2008 Mar;8(1):1-13. doi: 10.1007/s12012-007-9008-5. Epub 2008 Jan 5.
7
Using induced pluripotent stem cells for drug discovery in arrhythmias.利用诱导多能干细胞进行心律失常的药物发现。
Expert Opin Drug Discov. 2024 Jul;19(7):827-840. doi: 10.1080/17460441.2024.2360420. Epub 2024 Jun 2.
8
Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.多能干细胞在心律失常研究中的前景与挑战
Curr Cardiol Rep. 2017 Mar;19(3):23. doi: 10.1007/s11886-017-0828-z.
9
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.使用患者特异性诱导多能干细胞进行心血管疾病建模
Int J Mol Sci. 2015 Aug 12;16(8):18894-922. doi: 10.3390/ijms160818894.
10
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists.人诱导多能干细胞衍生心肌细胞作为心脏通道病模型:非电生理学家入门。
Circ Res. 2018 Jul 6;123(2):224-243. doi: 10.1161/CIRCRESAHA.118.311209.

本文引用的文献

1
NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells.NODAL 抑制促进人诱导多能干细胞向起搏样心肌细胞的分化。
Stem Cell Res. 2020 Dec;49:102043. doi: 10.1016/j.scr.2020.102043. Epub 2020 Oct 12.
2
Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity.利用患者诱导多能干细胞心肌细胞对心律失常药物进行再工程改造,以提高治疗潜力并降低毒性。
Cell Stem Cell. 2020 Nov 5;27(5):813-821.e6. doi: 10.1016/j.stem.2020.08.003. Epub 2020 Sep 14.
3
Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell-based therapy.
使用可溶性环氧化物水解酶抑制剂抑制炎症和纤维化可增强基于心脏干细胞的治疗。
Stem Cells Transl Med. 2020 Dec;9(12):1570-1584. doi: 10.1002/sctm.20-0143. Epub 2020 Aug 13.
4
Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.代谢成熟培养基可改善人诱导多能干细胞衍生心肌细胞的生理功能。
Cell Rep. 2020 Jul 21;32(3):107925. doi: 10.1016/j.celrep.2020.107925.
5
Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology.人工智能和机器学习在心律失常和心脏电生理学中的应用。
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e007952. doi: 10.1161/CIRCEP.119.007952. Epub 2020 Jul 6.
6
Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease.人诱导多能干细胞衍生的心脏基质细胞增强 3D 心脏微组织的成熟,并揭示非心肌细胞对心脏疾病的贡献。
Cell Stem Cell. 2020 Jun 4;26(6):862-879.e11. doi: 10.1016/j.stem.2020.05.004. Epub 2020 May 26.
7
Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes.使用人诱导多能干细胞衍生的心肌细胞进行药物诱导收缩力变化的盲法、多中心评估。
Toxicol Sci. 2020 Jul 1;176(1):103-123. doi: 10.1093/toxsci/kfaa058.
8
Characterization of Atrial and Ventricular Structural Remodeling in a Porcine Model of Atrial Fibrillation Induced by Atrial Tachypacing.心房超速起搏诱导的猪心房颤动模型中心房和心室结构重塑的特征
Front Vet Sci. 2020 Apr 9;7:179. doi: 10.3389/fvets.2020.00179. eCollection 2020.
9
Rabbit models of heart disease.心脏病的兔子模型。
Drug Discov Today Dis Models. 2008 Fall;5(3):185-193. doi: 10.1016/j.ddmod.2009.02.001. Epub 2009 Mar 17.
10
Human Purkinje in silico model enables mechanistic investigations into automaticity and pro-arrhythmic abnormalities.人类浦肯野细胞体内模拟技术可用于研究自动节律性和致心律失常性异常的机制。
J Mol Cell Cardiol. 2020 May;142:24-38. doi: 10.1016/j.yjmcc.2020.04.001. Epub 2020 Apr 3.